SCellex is a Finnish start-up company, developing a novel high throughput spatial transcriptomics method. It is based on visual barcoding of single cell sized picowells in an array with the help of random combinations of coloured feature barcode beads. The bead loaded, imaged and AI analyzed chips are then ready for RNA capture directly from tissue sections or from single cell suspensions in high throughput manner.
News:
9.4.2024 Two new open positions in R&D!
18.3.2024 SCellex is excited to have 2 new investors on board: Tuomas Tenkanen/TJT Technologies and Jean De Gunzburg, both very experienced in life science business. Looking forward to the journey together, welcome to the team!
26-27.10.2023 see you at Single Cell Omics symposium, Helsinki!
9-11.10.2023 let’s meet at SCG2023 in Engelberg, Switzerland!
30.8.2023 SCellex has a new CEO, Arto Forsberg – welcome to the team Arto!
14-17.6.2023 visit our booth at ISSCR 2023 in Boston!
12-15.6.2023 visit our booth at EACR 2023 in Turin!
4-7.6.2023 visit our booth at SSI2023 meeting in Turku
17-18.11.2022 SLUSH at Helsinki: SCellex was the winner of SLUSH Y-Science pitching competition!
17-19.10.2022 Meet us at Single Cell Genomics 2022, Utrecht! Come to chat at our 2 posters entitled: “Spatial scRNAseq of cells and tissues with visually barcoded beads on a picowell array” & “Spatial picowell array for high throughput functional single cell cultures and assays”.
28-29.9.2022 Meet us at Nordic Life Science Days, Malmö! Come to the Finland pavilion to meet and listen our pitch at 10:20 and 13:20 on 28th.
27.9.2022 We are seeking talents to strengthen the software development and business management teams! Please contact paivi.saavalainen@scellex.com for further details
3.8.2021 OPEN POSITION(S) IN R&D!
8.6.2020 SCellex and 10 other start-ups selected to the new Health Incubator Helsinki
11.5.2020 SCellex partners with a new CancerIO consortium project on immuno-oncology
17.3.2020 Instrumentarium Science Foundation grant for SCellex
1.2.2019 Runar Bäckström Foundation grant for SCellex
